Bill

Bill > S97


US S97

Affordable and Safe Prescription Drug Importation Act


summary

Introduced
01/10/2019
In Committee
01/10/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals. This bill addresses the importation of drugs from Canada and other foreign countries. The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries. The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.

AI Summary

This bill amends the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe prescription drugs by wholesale distributors, pharmacies, and individuals. The bill requires the Food and Drug Administration (FDA) to establish regulations within 180 days to permit the importation of qualifying prescription drugs from Canada. After two years, the FDA may also allow importation from other countries that have comparable drug safety standards to the United States. The bill establishes a certification process for foreign sellers, such as licensed foreign pharmacies and wholesale distributors, and sets requirements for individuals importing prescription drugs. The bill also prohibits drug manufacturers from engaging in discriminatory practices that limit the importation of drugs under this program.

Committee Categories

Health and Social Services

Sponsors (25)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 01/10/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...